DoW Breast Cancer, Breakthrough Award Levels 1 and 2
DoW Breast Cancer, Breakthrough Award Levels 1 and 2 is offered by Defense Health Agency Contracting Activity - DHACA. Max award: Not specified. Applications close on Nov 18, 2026.
| Opportunity number | HT942526BCRPBTA122 |
|---|---|
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Posted |
| Posted | Sep 3, 2026 |
| Closes | Nov 18, 2026 |
| Award ceiling | Not specified |
| Award floor | Not specified |
| Total program funding | $10,600,000 |
| Expected awards | 6 |
| Who can apply | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
| Category | Science and Technology and other Research and Development |
Summary (excerpt)
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Br…
View the official listing and apply on Grants.gov
Before you apply
- Register your organization in SAM.gov and get a UEI — it can take weeks
- Create a Grants.gov account and check eligibility in the full notice (NOFO)
- Start early; the system gets busy near deadlines
Grants closing soon · More from Defense Health Agency Contracting Activity - DHACA